Aetna Beats 4Q Profit ForecastsAetna is reporting a better-than-expected profit of $244 million for the fourth quarter.
Aetna 3Q Profit Soars, Issues Strong ForecastAetna trumped third-quarter earnings expectations and raised its 2017 forecast again even as the health insurer's withdrawal from the Affordable Care Act's insurance marketplaces contributed to a revenue hit.
UTC Reports 2Q Profit Boost, Raises OutlookUnited Technologies Corp. on Tuesday reported a boost in second-quarter profit on sales gains from key business units while also raising its outlook.
Aetna Posts 1Q Loss On Failed Humana Bid, Ups 2017 ForecastAetna booked a $381-million, first-quarter loss mainly due to its failed bid for rival Humana, but the nation's third largest health insurer still beat earnings expectations and raised its 2017 forecast.
United Technologies Beats Street 1Q ForecastsUnited Technologies Corp. on Wednesday reported first-quarter profit of $1.39 billion.
Aetna Tops 4Q Forecasts, Starts Low With 2017 ForecastAetna trumped analyst earnings expectations for the final quarter of 2016, but the health insurer's 2017 forecast starts off well below Wall Street projections.
UTC Meets Wall Street's Earnings ExpectationsFarmington-based United Technologies reports a fourth-quarter profit of $1.01 billion.
Aetna Tops Street 3Q Expectations, Narrows 2016 ForecastAetna's third-quarter earnings rose nearly 8 percent to top Wall Street forecasts, as growing government business and cost cutting helped counter higher costs from the health insurer's Affordable Care Act coverage.
Cigna Reports Q2 EarningsCigna's second-quarter earnings rose nearly 3 percent, beating estimates as the health insurer had predicted last week when it announced a plan to combine with bigger rival Anthem in a $48-billion deal.
UTC 2nd Q Earnings Beat Wall Street Forecast United Technologies Corp. (UTX) on Tuesday reported second-quarter net income of $1.54 billion.
United Tech Warns Against Double-digit Profit Rise In 2015The chief executive of United Technologies Corp. has warned investor analysts against expecting double-digit earnings growth this year because of a strong dollar that's making exports more expensive and pension funding.
Pfizer Earnings Down From Last Year, Still Exceed Expectations Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.